Drug search by name

Topiramate Extended-Release Capsules and Angle closure glaucoma

Result of checking the interaction of drug Topiramate Extended-Release Capsules and disease Angle closure glaucoma for safety when used together.

Check result:

Topiramate Extended-Release Capsules <> Angle closure glaucoma

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

A syndrome consisting of acute myopia associated with secondary angle closure glaucoma has been reported in patients receiving topiramate. Symptoms include acute onset of visual acuity and/or ocular pain. It typically occurs within 1 month of treatment initiation and it has been reported in both pediatric and adult patients. Caution is recommended when prescribing topiramate in patients with elevated intraocular pressure regardless of the etiology.

Topiramate Extended-Release Capsules

Generic Name: topiramate

Brand Name: Qudexy XR Sprinkle, Topamax, Topamax Sprinkle, Trokendi XR, Topiragen, Qudexy XR

Synonyms: Topiramate

What is Topiramate Extended-Release Capsules?